Viewing Study NCT03742102


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-02-26 @ 4:14 PM
Study NCT ID: NCT03742102
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-14
First Post: 2018-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-12-21
Start Date Type: ACTUAL
Primary Completion Date: 2024-11-29
Primary Completion Date Type: ACTUAL
Completion Date: 2027-02-26
Completion Date Type: ESTIMATED
First Submit Date: 2018-10-25
First Submit QC Date: None
Study First Post Date: 2018-11-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-10-13
Last Update Post Date: 2025-10-14
Last Update Post Date Type: ESTIMATED